Skincare Sampling Process: How to Move From Product Brief to an Approved Production Sample

01

Define what the first sample must prove

Give each sample a decision role

A sample request should start with the decision the physical product needs to support. An early private-label sample may confirm whether an established formula fits the brand’s sensory direction. An OEM sample may test how closely a technical brief or benchmark can be translated. An ODM sample may explore a wider concept before the formula and pack are narrowed.

Write the full use context

Write the category, routine role, target user, target country, format, texture, finish, fragrance position, colour, fill size, packaging direction and launch channel. Add the features that are mandatory, preferred or open. The cosmetic formulation guide helps organise a concept into a more usable formula brief.

Annotate the benchmark

If a benchmark is included, annotate it. Explain whether the reference is about slip, absorption, residue, fragrance, opacity, dispense, after-feel or retail presentation. “Make this premium” is too broad; “fast-absorbing gel-cream with low tack under sunscreen” gives the formulator something observable to assess.

• Customer and routine role.
• Target market, channel and price position.
• Texture, appearance, fragrance and finish.
• Benchmark attributes to retain or change.
• Pack format, fill, timing and open questions.

02

Create a version system before feedback begins

Identify every physical version

Every sample should arrive with an identifier that connects it to a formula or product record. Capture the date, version code, format, fragrance or colour variation, intended component, requested changes and the purpose of that round. Photographing several unlabelled jars on a phone is not reliable version control.

Separate observations from actions

Use one feedback record for the full decision team. Separate observations from requested actions: “feels tacky after two minutes” is an observation; “reduce tack without making the cream more fluid” is a direction. Mark whether a request is essential, preferred or exploratory, and identify who is authorised to consolidate comments.

Compare rounds, not memories

Keep earlier versions until the direction is closed. Side-by-side comparison can reveal that a new round solved one issue but weakened another. A sample round is useful only when the team can state what changed, what improved and which questions remain open.

03

Evaluate sensory performance consistently

Use a category-specific review

Define a simple evaluation method that matches expected use. For a face serum, the team might review appearance, odour, spread, absorption, tack, pilling and after-feel at set intervals. A cleanser may require water temperature, dose, lather, rinse and post-rinse observations. A body product may need a larger application area and a review of clothing contact.

Control the evaluation conditions

Control enough variables to make feedback interpretable. Use the same amount, skin area, preceding routine and observation times where practical. Ask reviewers to note conditions that could influence the result, such as very dry skin, high humidity or application over another product. This does not turn an internal review into a clinical test; it simply improves decision quality.

Connect preference with the customer promise

Collect individual observations before a group discussion so the loudest voice does not set the result. Look for repeated patterns and link preferences back to the customer promise. A sensorial change is valuable when it helps the intended product work better in its real routine, not merely because it feels novel in a meeting.

04

Separate formula, packaging and artwork gates

Give each workstream its own question

Formula, primary packaging and artwork answer different questions. A formula sample can establish texture and finish without proving long-term pack compatibility. A component sample can demonstrate feel, dose and closure without proving that the final decorated pack will survive transport. An artwork proof can establish hierarchy and legibility without confirming that the underlying formula is approved.

Sequence connected decisions

Plan these gates in a logical sequence while allowing the workstreams to inform one another. A highly viscous formula may narrow pump choices. A small pack may reveal that required label information does not fit. A decoration process may affect component lead time. LUXA’s packaging planning process helps brands review function, compatibility and presentation together.

Record conditional approvals

Name what is provisional at each gate. The team may approve formula direction subject to fragrance adjustment, or select a component subject to compatibility work. Conditional decisions are valid when the condition is written and owned; they become risky when everyone informally treats them as final.

05

Plan testing around the final configuration

Do not confuse preference with safety evidence

Internal sensory approval is not product safety substantiation. Testing needs depend on the formula, packaging, intended use, consumer group, market and qualified assessment. The FDA’s product testing overview explains that cosmetics must be safe under labelled or customary use and that product testing is one way a manufacturer may support safety.

Test an identifiable product and pack

Stability, microbiological quality, preservation and packaging compatibility should be planned against identifiable versions. If the fragrance, preservative system, component material or closure changes, ask whether prior work still represents the product. The cosmetic stability-testing guide explains how to organise conditions, observations, pack interaction and shelf-life decisions.

Set decision rules in advance

Agree the acceptance criteria before results arrive. Define who reviews appearance, odour, pH or viscosity where relevant, microbiological findings, pack function and other product-specific measures. A pass/fail statement is more useful when the protocol, sample identity, conditions and decision rules are visible.

06

Review claims and target-market information early

Challenge the claim direction

Sampling is the right time to challenge the proposed product story. Claims can influence formula expectations, test needs, intended use and product classification. In the United States, FDA states that cosmetic claims must be truthful and not misleading, and that claims to treat or prevent disease or affect body structure or function may cause a product to be regulated as a drug. Review the official cosmetics labelling claims guidance before the front panel becomes fixed.

Prepare market information from controlled data

The target market also affects the information required for review. Health Canada’s current cosmetic notification guide covers product identification, manufacturer and importer details, use, form and ingredient concentrations. That work should be prepared from controlled product information, not reconstructed after artwork approval.

Give artwork enough time for review

Use the cosmetic label planning guide to organise identity, quantity, ingredient, business, warning and claim decisions. The manufacturer can provide formula and production information, while the brand and qualified advisers confirm final market obligations.

07

Approve the exact combination, not an idea

Write the complete approval record

Final sample approval should name the formula code, sample date, primary component and closure, fill size, fragrance or colour, decoration, artwork revision and any open testing or documentation item. Attach images where useful, but do not rely on images as the only record. The written approval should state who approved and for which production scope.

Use retained samples with context

Some teams keep a retained “golden sample” as a practical visual and sensory reference. It can help during first-production review, but it has limits: a physical sample can age, storage can alter it, and appearance alone cannot replace specifications or batch records. Use it as one reference inside a controlled file.

Reopen the right checks after a change

If anything changes after approval, assess the consequence. A different pump, label material, supplier, fragrance level or fill can affect compatibility, appearance, process, claims or timing. Approval should close a defined version; change control should govern the next one.

08

Hand the approved sample into production

Translate approval into operating instructions

The production handover should convert development decisions into a scope that operations can follow. Confirm formula and component codes, approved artwork, target quantity, pack-out, coding, required checks, release responsibilities, destination and requested timing. Identify remaining dependencies and the latest date each must close.

Separate production from market release

For Great Britain, official cosmetics market guidance explains that the Responsible Person must ensure the safety assessment, maintain the Product Information File, notify the product and support claims before it is made available. Factory completion and market release are connected, but they are not the same decision.

Plan the first-run review

Schedule a first-run review so the team knows how appearance, fill, coding, component performance and pack-out will be assessed. Keep the approved records available for repeat production. When the sample brief is ready, send the category, market, route, benchmark, pack direction and decision timeline through LUXA’s project enquiry.

• Approved formula and sample version.
• Primary pack, closure, fill and decoration.
• Artwork revision, coding and pack-out.
• Testing, release and market-review status.
• Quantity, destination, timing and decision owners.